USD 120.00
In stock
Be the first to review this item
Androcur (Androkur) - antiandrogenic, gestagenic.
Oral antiandrogenic drug. It inhibits the impact of male sex hormones (androgens), in small quantities produced by the body of a woman. Has a gestagenic, antiandrogenic and antigonadotropic effect.
In men against the background of taking the drug, there is a weakening of sexual desire and potency, as well as a decrease in the function of the testes. These changes disappear after the cessation of treatment. The drug reduces or completely eliminates the effect of androgens on the target organs (including the prostate gland).
In women, when Androcur is taken, both abnormally excessive growth of hair on the face and body, as well as the loss of hair on the head caused by androgens, is reduced. In addition, the increased function of the sebaceous gland decreases and is inhibited during the treatment period by the function of the ovaries.
Indications:
Manifestations of androgenization of moderate severity in women, such as:
Contraindications:
Contraindications for the use of the Diane-35 preparation, which is prescribed in combination with the Androcur preparation, should also be considered.
With caution: Patients with diabetes mellitus; diseases / conditions requiring compliance with the precautionary measures when using the drug Diane-35.
Special instructions:
In patients with carcinoma of the prostate and the presence of severe diabetes with vascular changes, sickle cell anemia or previous thromboembolic events, when deciding whether to prescribe Androcur, individual benefits and risks of developing negative effects of treatment should be weighed individually.
Patients before the start of Androcur therapy should undergo general medical care, and the patients should additionally have a gynecological examination to exclude pregnancy.
If the Androkur and Diana-35 are taken together, the patient should be informed that if the patient misses the Androcur and / or Diane-35 dragees at the usual time, the drug should be taken no later than the next 12 hours. If the above time is exceeded, the contraceptive effect for this cycle is not provided. Receiving Androcur tablets or Diane-35 dragees should be continued on time from the packs started, bypassing the forgotten tablets and / or dragees in order to prevent premature bleeding in this cycle. In addition to the end of this cycle, it is necessary to use other, non-hormonal methods of preventing conception. If this cycle does not end with bleeding, discontinue therapy and conduct a survey.
With simultaneous use of alcohol, which exerts a disinhibitory effect, in patients with pathologically elevated sexual desire, a decrease in the effect of Androcur therapy can be observed.
Control of laboratory indicators
During the treatment with the drug, careful monitoring of liver function and peripheral blood pattern is necessary.
Impact on the ability to drive vehicles and other mechanisms that require increased concentration
Patients whose activities require increased attention should take into account that when taking Androcur can experience increased fatigue, lethargy, decreased ability to concentrate.
Suggested Use:
Application in Women
In cases of androgenation of moderate severity, the drug is taken in the form of tablets 10 mg daily from the 1st to the 15th day of the menstrual cycle at a dose of 10 mg once a day. Androcur in the form of tablets 10 mg are taken with the drug Diane-35 to obtain the necessary contraceptive effect and exclude intermenstrual bleeding.
To stabilize the cycle and for the purpose of reliable contraception, patients with androgenation phenomena are additionally taken from the 1st to the 21st days of the cycle Diane-35 preparation for 1 dragee / day at the same time. Admission of both drugs should begin on the 1st day of the cycle (the first day of bleeding). After the termination of Androcur's administration (the 10th or 15th day of the cycle) during the following days of the cycle, the remaining tablets are taken from the calendar package of Diane-35 preparation (total 21 days). Then there is a break of 7 days, during which bleeding should occur. After a 7-day pause, the reception is continued from the following calendar packs of drugs Androkur and Diana-35, regardless of whether the bleeding has ended or is still ongoing. If after the end of taking pills bleeding has not occurred, treatment should be discontinued and a survey.
The duration of treatment is determined by the doctor and depends on the type, as well as the severity of the pathological phenomena of androgenization and the results of treatment. Acne and seborrhea usually give in to cure earlier than alopecia.
Androcur tablets are taken orally after eating, with a small amount of liquid.
Packaging:
Comes in original packaging. Item is brand new and unopened.
Storage:
Keep away from direct sunlight.
Keep locked and away from children.
Store in dry place at room temperature.
Do not exceed storage temperature higher than 25 C
Important notice- the outer box design may vary before prior notice!